Masayoshi Sawaki

509 total citations
39 papers, 359 citations indexed

About

Masayoshi Sawaki is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Immunology. According to data from OpenAlex, Masayoshi Sawaki has authored 39 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 11 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in Masayoshi Sawaki's work include Tracheal and airway disorders (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Mycobacterium research and diagnosis (4 papers). Masayoshi Sawaki is often cited by papers focused on Tracheal and airway disorders (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Mycobacterium research and diagnosis (4 papers). Masayoshi Sawaki collaborates with scholars based in Japan, Singapore and Bulgaria. Masayoshi Sawaki's co-authors include Nobuhiro Narita, Keiichi Mikasa, Eiji Kita, Mitsuru Konishi, Shuzo Kashiba, Shoji Takeuchi, Kaoru Hamada, Kaoru Hamada, Masahiro Sakamoto and Masashi Emoto and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, Pharmacology and Chemotherapy.

In The Last Decade

Masayoshi Sawaki

37 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masayoshi Sawaki Japan 10 132 115 101 67 43 39 359
Fuminari Sonoda Japan 9 174 1.3× 91 0.8× 98 1.0× 154 2.3× 29 0.7× 13 427
Houria Abdelghaffar France 11 96 0.7× 68 0.6× 172 1.7× 122 1.8× 68 1.6× 24 433
Jean-Christophe Beaudoin France 8 66 0.5× 202 1.8× 77 0.8× 22 0.3× 33 0.8× 10 559
Osamu Sakito Japan 5 272 2.1× 49 0.4× 141 1.4× 95 1.4× 10 0.2× 13 445
Martin Rr Cuba 12 93 0.7× 98 0.9× 46 0.5× 78 1.2× 9 0.2× 41 418
K. Bartmann Germany 9 50 0.4× 31 0.3× 66 0.7× 36 0.5× 24 0.6× 67 242
K. Taniguchi Japan 13 59 0.4× 123 1.1× 63 0.6× 374 5.6× 11 0.3× 35 620
Xuefeng Li China 11 39 0.3× 150 1.3× 146 1.4× 83 1.2× 16 0.4× 43 384
E N Brunette United States 7 97 0.7× 67 0.6× 182 1.8× 75 1.1× 4 0.1× 7 359
Kathryn Chmura United States 10 70 0.5× 85 0.7× 190 1.9× 109 1.6× 8 0.2× 13 443

Countries citing papers authored by Masayoshi Sawaki

Since Specialization
Citations

This map shows the geographic impact of Masayoshi Sawaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayoshi Sawaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayoshi Sawaki more than expected).

Fields of papers citing papers by Masayoshi Sawaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayoshi Sawaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayoshi Sawaki. The network helps show where Masayoshi Sawaki may publish in the future.

Co-authorship network of co-authors of Masayoshi Sawaki

This figure shows the co-authorship network connecting the top 25 collaborators of Masayoshi Sawaki. A scholar is included among the top collaborators of Masayoshi Sawaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayoshi Sawaki. Masayoshi Sawaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Teramoto, S., Eiji Kita, Keiichi Mikasa, et al.. (1997). Expression of IL-12 mRNA in peripheral blood mononuclear cells from inoperable non-small cell lung cancer patients treated with clarithromycin.. Chemotherapy. 45(3). 144–147. 3 indexed citations
2.
Kobayashi, Atsushi, Koichi Maeda, Keiichi Mikasa, et al.. (1997). Metastatic Tumor Presenting as Otitis Media in Primary Lung Cancer.. Haigan. 37(3). 379–383.
3.
Takeuchi, Shoji, Masayoshi Sawaki, Mitsuru Konishi, et al.. (1995). Determination of the Neutrophil Function in the Respiratory Infection by Chemiluminescence (CL). Kansenshogaku zasshi. 69(1). 54–59. 1 indexed citations
4.
Uchida, Hideo, et al.. (1995). Clinical aerosol inhalation cine-scintigraphy to evaluate mucociliary transport system in diffuse panbronchiolitis.. PubMed. 36(8). 1355–62. 3 indexed citations
5.
Sakamoto, Masahiro, Kenta Hamada, M. Konishi, et al.. (1995). [Effect of clarithromycin treatment of natural killer cell activity in patients with advanced non-small cell lung cancer].. Acta Scientiarum Naturalium Universitatis Sunyatseni. 2(14). 12–16. 9 indexed citations
6.
Hamada, Kaoru, et al.. (1995). Antitumor Effect of Erythromycin in Mice. Chemotherapy. 41(1). 59–69. 29 indexed citations
7.
Kita, Eiji, Masayoshi Sawaki, Keiichi Mikasa, et al.. (1993). Alterations of host response by a long-term treatment of roxithromycin. Journal of Antimicrobial Chemotherapy. 32(2). 285–294. 17 indexed citations
8.
Sawaki, Masayoshi, Eiji Kita, Keiichi Mikasa, et al.. (1993). Restoration of the acute phase response after infection in cyclophosphamide-treated mice by granulocyte colony-stimulating factor. Biotherapy. 6(1). 51–61. 1 indexed citations
9.
Sawaki, Masayoshi, et al.. (1992). Two Cases of Diffuse Panbronchiolitis Receiving Long-Term Erythromycin (EM) Therapy with Acute Exacerbation due to EM-Resistant Pneumococcus. Kansenshogaku zasshi. 66(6). 737–742. 1 indexed citations
10.
Mikasa, Keiichi, et al.. (1990). Fever induced by antibacterial drugs. Chemotherapy. 38(1). 21–25. 1 indexed citations
11.
Sawaki, Masayoshi, et al.. (1990). A Clinical Study on Five Cases of Respiratory Infections Caused by Neisseria meningitidis. Kansenshogaku zasshi. 64(7). 822–829. 2 indexed citations
12.
Sawaki, Masayoshi, et al.. (1989). Inhibitory Effect of Erythromycin on Elastase producing Ability of Pseudomonas aeruginosa. Kansenshogaku zasshi. 63(10). 1212–1214. 3 indexed citations
13.
Mikasa, Keiichi, Masayoshi Sawaki, Mitsuru Konishi, et al.. (1989). The Effect of Erythromycin Treatment of Natural Killer (NK) Cell Activity in Patients with Chronic Lower Respiratory Tract Infections. Kansenshogaku zasshi. 63(8). 811–815. 7 indexed citations
14.
Sawaki, Masayoshi, et al.. (1986). The Long Term Chemotherapy with Erythromycin in Chronic Lowe Respiratory Tract Infections. Kansenshogaku zasshi. 60(1). 45–50. 19 indexed citations
15.
Sawaki, Masayoshi, et al.. (1986). The Long Term Chemotherapy with Erythromycin in Chronic Lower Respiratory Tract Infections. Kansenshogaku zasshi. 60(1). 37–44. 14 indexed citations
16.
Sawaki, Masayoshi, et al.. (1985). One case of subphrenic abscess caused by Streptococcus agalactiae in uncontrollable diabetes mellitus. Kansenshogaku zasshi. 59(1). 51–56. 2 indexed citations
17.
Mikasa, Keiichi, Hitoshi Katada, Shinsaku Ito, et al.. (1985). Transmyocardial metastasis of a lung cancer showing a recent myocardial infarction-like ECG: Report of a case with autopsy findings.. Haigan. 25(1). 93–98. 2 indexed citations
18.
Katada, Hitoshi, Riichiro Mikami, Kiyoshi Nishikawa, et al.. (1984). SERUM IgE LEVEL IN PULMONARY TUBERCULOSIS. 59(9). 483–490. 1 indexed citations
19.
Ito, Shinsaku, et al.. (1984). [Mucociliary clearance in diffuse panbronchiolitis, pulmonary emphysema and chronic bronchitis estimated by aerosol inhalation cine-scintigraphy].. PubMed. 22(6). 479–85.
20.
Sawaki, Masayoshi, et al.. (1982). Studies of Role of Normal Upper Airway Flora in Lower Respiratory Tract Infection by Transtracheal Aspiration. Kansenshogaku zasshi. 56(9). 789–798. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fuminari Sonoda Breakdown of academic impact, for papers by Houria Abdelghaffar Breakdown of academic impact, for papers by Jean-Christophe Beaudoin Breakdown of academic impact, for papers by Osamu Sakito Breakdown of academic impact, for papers by Martin Rr Breakdown of academic impact, for papers by K. Bartmann Breakdown of academic impact, for papers by K. Taniguchi Breakdown of academic impact, for papers by Xuefeng Li Breakdown of academic impact, for papers by E N Brunette Breakdown of academic impact, for papers by Kathryn Chmura
Rankless by CCL
2026